HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.
![handle is hein.congrecreports/crptxsyt0001 and id is 1 raw text is: AUTHENTICATEO
U.S. GOVERNMENT
INFORMATION
Gp
114TH CONGRESS JREPT. 114 41
1st Session HOUSE OF REPRESENTATIVES Part 1
IMPROVING REGULATORY TRANSPARENCY FOR NEW
MEDICAL THERAPIES ACT
MARCH 16, 2015.-Committed to the Committee of the Whole House on the State
of the Union and ordered to be printed
Mr. UPTON, from the Committee on Energy and Commerce,
submitted the following
REPORT
[To accompany H.R. 639]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 639) to amend the Controlled Substances Act with re-
spect to drug scheduling recommendations by the Secretary of
Health and Human Services, and with respect to registration of
manufacturers and distributors seeking to conduct clinical testing,
having considered the same, report favorably thereon with amend-
ments and recommend that the bill as amended do pass.
CONTENTS
Page
Purpose and Sum m ary ........................................................................................... 4
Background and Need for Legislation ................................................................... 5
H earings ................................................................................................................... 6
Com m ittee Consideration ....................................................................................... 6
C om m ittee V otes ...................................................................................................... 6
Com m ittee Oversight Findings ............................................................................... 6
Statement of General Performance Goals and Objectives .................................... 6
New Budget Authority, Entitlement Authority, and Tax Expenditures ............. 7
Earmark, Limited Tax Benefits, and Limited Tariff Benefits ............................. 7
Com m ittee Cost Estim ate ....................................................................................... 7
Congressional Budget Office Estimate ................................................................... 7
Federal M andates Statem ent ................................................................................. 7
Duplication of Federal Program s ........................................................................... 7
Disclosure of Directed Rule M akings .................................................................... 7
Advisory Com m ittee Statem ent ............................................................................. 7
Applicability to Legislative Branch ....................................................................... 7
Section-by-Section Analysis of the Legislation ...................................................... 8
Changes in Existing Law Made by the Bill, as Reported .................................... 8
Exchange of Letters with Additional Committees of Referral ............................. 132
The amendments are as follows:
Strike all after the enacting clause and insert the following:
49-006](ViewImageLocal?handle=hein.congrecreports/crptxsyt0001&div=1&collection=&method=preview&ext=.png&size=3)